Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Combined Digital X-ray and Ultrasound Technique for Improved Detection and Characterization of Breast Lesions

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Paul L. Carson Ph.D, University of Michigan
ClinicalTrials.gov Identifier:
NCT00721435
First received: July 22, 2008
Last updated: July 1, 2014
Last verified: July 2014
  Purpose

The study will evaluate and refine a breast screening and diagnosis device.


Condition Intervention
Breast Cancer
Mass Cystic
Benign Mass
Procedure: Tomosynthesis and ultrasound imaging

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Combined Digital X-ray and Ultrasound Technique for Improved Detection and Characterization of Breast Lesions

Resource links provided by NLM:


Further study details as provided by University of Michigan:

Primary Outcome Measures:
  • To have a device that produces 3D/ultrasound imaging of the breast at the same time and in the same position. [ Time Frame: To be determned later. ] [ Designated as safety issue: No ]

Estimated Enrollment: 260
Study Start Date: April 2002
Estimated Study Completion Date: December 2014
Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: A
Evaluating a non-invasive breast screening and diagnostic device, 3D tomosynthesis and 3D ultrasound. Evaluate the utility of adding ultrasound.
Procedure: Tomosynthesis and ultrasound imaging
3D and ultrasound imaging for breast abnormalities and masses

Detailed Description:

The device produces 3-D mammograms and ultrasound pictures of the breast at the same time and in the same position. This should help make sure that any area on a mammogram can be easily found in the ultrasound when using the new device. The 3-D mammograms should provide better visualization of the suspected lesion and improve diagnostic accuracy.

  Eligibility

Ages Eligible for Study:   25 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • To participate in this research study you must be a female over the age of 25
  • Have had a normal mammogram or are scheduled for a breast biopsy
  • Have cysts or have been recommended to have a 6 month follow up mammogram after your biopsy.

Exclusion Criteria:

  • Male
  • Under the age of 25
  • Documented breast cancer
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00721435

Locations
United States, Michigan
University of Michigan
Ann Arbor, Michigan, United States, 48109
University of Michigan
Ann Arbor, Michigan, United States, 48109-0554
Sponsors and Collaborators
University of Michigan
Investigators
Principal Investigator: Paul L Carson, PHD University of Michigan
  More Information

No publications provided

Responsible Party: Paul L. Carson Ph.D, Principal Investigator, University of Michigan
ClinicalTrials.gov Identifier: NCT00721435     History of Changes
Other Study ID Numbers: HUM00045519 (2002-0584)
Study First Received: July 22, 2008
Last Updated: July 1, 2014
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Breast Neoplasms
Breast Diseases
Neoplasms
Neoplasms by Site
Skin Diseases

ClinicalTrials.gov processed this record on November 20, 2014